Principal Scientist, Protein Characterization

AstraZenecaNew Haven, CT
1dOnsite

About The Position

We are seeking an innovative Principal Scientist to join the Protein Characterization group within Analytical Development & Quality Control (ADQC) at Alexion, AstraZeneca Rare Disease. This is an on-site role based in New Haven, CT. The successful candidate will be a scientific and technical leader. They will deliver proficiency in liquid chromatography method development, fractionation, and characterization of charge, size, and other product-related variants for biologics. This role plays a critical part in supporting biologics development throughout both clinical trials and market launch phases, including CQA assessment, forced degradation studies, and comparability evaluations.

Requirements

  • BS with 12 years of experience, MS with 10 years of relevant industry experience, or PhD with a of 6 years of relevant industry experience
  • Deep expertise in developing and applying methods related to liquid phase chromatography for biologics.
  • Strong experience with charge and size variant or other product-related variant characterization.
  • Proven experience with fractionation techniques to support structural and functional characterization.
  • Solid understanding of protein degradation pathways and analytical approaches for forced degradation.
  • Experience supporting CQA assessment and comparability studies.
  • Familiarity with cGMP expectations, data integrity, and regulatory requirements for analytical development.
  • Strong data interpretation, problem-solving, and scientific interpersonal skills.
  • The duty of this role involves lab-based work. Employees must be able, with or without accommodation, to lift/carry 15/30 pounds unassisted/assisted.

Nice To Haves

  • Extensive hands-on experience in protein characterization for biologics within a pharmaceutical or biotechnology environment.
  • Experience supporting late-stage development and/or commercial products.
  • Prior involvement in regulatory submissions or health authority interactions.
  • Demonstrated leadership in cross-functional analytical strategy development.

Responsibilities

  • Serve as a technical subject matter expert (SME) in LC-based protein variant characterization, including method development, optimization, fractionation, and troubleshooting!
  • Lead and implement fractionation studies to isolate and characterize product-related variants.
  • Build, develop, and apply methods for charge variant (e.g., IEX, icIEF), size variant (e.g., SEC, CE-SDS), or other product-related variant characterization of biologics.
  • Support and/or lead forced degradation studies to assess product stability and degradation pathways.
  • Perform and interpret data for critical quality attribute (CQA) assessment and risk evaluation.
  • In depth understanding of product comparability assessment supporting process changes at clinical and commercial stages.
  • Author, review, and approve technical documentation, including development reports related to protein forced degradation, fractionation, comparability, and CQA, as well as regulatory submissions (IND, BLA, MAA).
  • Mentor and provide scientific guidance to junior scientists, contributing to team capability building and technical excellence.
  • Partner cross-functionally with Process Development, CMC, Regulatory, Quality, and Manufacturing teams to ensure robust analytical strategies aligned with project and regulatory expectations.
  • Represent ADQC in internal governance forums and external interactions, as appropriate.
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service